Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20
tirzepatide and cyclobenzaprine Hydrochloride Extended-release Tablets at 456.00 INR in Mumbai Not all GLP-1–based therapies Summer Flavor:Raspberry
Not all GLP-1–based therapies work the same way. Semaglutide targets the GLP-1 receptor, while tirzepatide targets both GLP-1 and GIP receptors. Retatrutide is being studied as a triple-receptor agonist targeting GLP-1, GIP
Foundayo (Orforglipron): This once-daily oral medication, newly approved for GLP-1 weight loss management, offers flexibility with no food or water restrictions
Summer
Flavor:Raspberry
Lebrun et al., 2017
US$ 23.53
US$ 22.90
US$ 22.98
US$ 27.48
US$ 21.44
US$ 20.94
US$ 20.44
US$ 20.05
